Notice of Change to Application Types Allowed for PA-16-144 "Role of Astrocytes and Astrocytic Networks in Drug Abuse (R01)"

Notice Number: NOT-DA-16-030

Key Dates
Release Date: May 12, 2016

Related Announcements
PA-16-144

Issued by
National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this Notice is to update the Application Types Allowed information in PA-16-144" "Role of Astrocytes and Astrocytic Networks in Drug Abuse (R01)". This update is effective September 8, 2016.

Part 2. Section II. Award Information

Current Text:

Application Types Allowed

New

The OER Glossary and the SF424 (R&R) Application Guide provide details on these application types.

New Text:

Application Types Allowed

New
Renewal
Resubmission
Revision

The OER Glossary and the SF424 (R&R) Application Guide provide details on these application types.

Part 2. Section V. Application Review Information

1. Criteria

Current Text:

Resubmissions

Not Applicable

Renewals

Not Applicable

Revisions

Not Applicable

New Text:

Resubmissions

For Resubmissions, the committee will evaluate the application as now presented, taking into consideration the responses to comments from the previous scientific review group and changes made to the project.

Renewals

For Renewals, the committee will consider the progress made in the last funding period.

Revisions

For Revisions, the committee will consider the appropriateness of the proposed expansion of the scope of the project. If the Revision application relates to a specific line of investigation presented in the original application that was not recommended for approval by the committee, then the committee will consider whether the responses to comments from the previous scientific review group are adequate and whether substantial changes are clearly evident.

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Roger G Sorensen, Ph.D., MPA
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-3205
Email: rsorense@mail.nih.gov